Analystreport

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) is now covered by analysts at Leerink Swann. They set an "outperform" rating on the stock.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report